关于UGT1A4和UGT2B7多态性对双相情感障碍患者拉莫特里金血度的影响
Ting Zhao1,2, Hui-Lan Zhang1,2, Jie Feng1,2
1Department of Pharmacy.
在UGT1A4和UGT2B7的遗传变异影响了中国双相情感障碍患者的拉莫特里金水平. 这些尿素5'-二酸-葡萄糖酶转移酶多态性是lamotrigine药理动学的关键因素.
科学领域:
- 药物基因组学 药物基因组学
- 神经科学是一个神经科学.
- 临床化学 临床化学
背景情况:
- 双极性障碍的治疗通常涉及拉莫特里金,一种情绪稳定剂.
- 个人对拉莫特里金的反应可能会有很大差异.
- 人们越来越认识到遗传因素会影响药物的疗效和安全性.
研究的目的:
- 研究UGT1A4和UGT2B7基因多态化对拉莫特里金血度的影响.
- 了解这些基因变异在被诊断患有双相情感障碍的中国患者中的作用.
主要方法:
- 招募了104名患有双相情感障碍的中国患者.
- 使用超高性能液体染色学测量了平稳状态的拉莫特里金血水平.
- 进行了UGT1A4 -142T>G和UGT2B7 -161C>T多态的基因定型.
主要成果:
- 根据UGT1A4和UGT2B7基因型,观察到拉莫特里金度/剂量比的显著差异.
- 特定的基因型 (例如,UGT1A4 GG/GT,UGT2B7 TT) 与较高的拉莫特里金水平有关.
- 多重回归确定了性别,拉莫特里金剂量和研究的多态性作为拉莫特里金药理动学的显著预测因素.
结论:
- UGT1A4 -142T>G和UGT2B7 -161C>T的多态性显著影响了拉莫特林的血度.
- 这些发现突显了药物遗传学在优化双相情感障碍的拉莫特林治疗中的重要性.
- 基因查可能有助于个性化lamotrigine剂量策略.
更多相关视频
07:00A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Mania and Antimanic Drugs: Overview
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Hepatic Drug Clearance: Role of Transporters
Phase II Reactions: Glucuronidation
